Cargando…
Lipoic Acid-Modified Oligoethyleneimine-Mediated miR-34a Delivery to Achieve the Anti-Tumor Efficacy
MiR-34a, an important tumor suppressor, has been demonstrated to possess great potential in tumor gene therapy. To achieve the upregulation of miR-34a expression level, an oligoethyleneimine (OEI) derivative was constructed and employed as the carrier through the modification with lipoic acid (LA),...
Autores principales: | Huang, Yu, Wang, Longxiang, Chen, Yingxuan, Han, Haobo, Li, Quanshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400101/ https://www.ncbi.nlm.nih.gov/pubmed/34443415 http://dx.doi.org/10.3390/molecules26164827 |
Ejemplares similares
-
Nucleolin-Targeting AS1411 Aptamer-Modified Micelle for the Co-Delivery of Doxorubicin and miR-519c to Improve the Therapeutic Efficacy in Hepatocellular Carcinoma Treatment
por: Liang, Xiao, et al.
Publicado: (2021) -
Fluorinated polyamidoamine dendrimer-mediated miR-23b delivery for the treatment of experimental rheumatoid arthritis in rats
por: Han, Haobo, et al.
Publicado: (2023) -
Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery
por: Wang, Yingying, et al.
Publicado: (2023) -
Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates: In Vivo Virulence Assessment in Galleria mellonella and Potential Therapeutics by Polycationic Oligoethyleneimine
por: Mil-Homens, Dalila, et al.
Publicado: (2021) -
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)